Try our Advanced Search for more refined results

March 17, 2015

Keen v. Teva Pharmaceuticals USA, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 04, 2017

    Teva Ducks Whistleblower's Off-Label Marketing FCA Suit

    An Illinois federal judge on Wednesday dismissed a Teva sales representative's whistleblower suit alleging the drugmaker violated the False Claims Act by pushing muscle relaxer Amrix for unapproved uses, ruling the whistleblower didn't give necessary specifics about what false claims were allegedly submitted to the government. 

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login